Genomic Features of Muscle-invasive Bladder Cancer Arising After Prostate Radiotherapy

European Urology ◽

10.1016/j.eururo.2021.12.004 ◽

2021 ◽

Author(s):

Matthew Mossanen ◽

Filipe L.F. Carvalho ◽

Vinayak Muralidhar ◽

Mark A. Preston ◽

Brendan Reardon ◽

...

Keyword(s):

Bladder Cancer ◽

Invasive Bladder Cancer ◽

Muscle Invasive Bladder Cancer ◽

Genomic Features ◽

Prostate Radiotherapy ◽

Muscle Invasive

Download Full-text

Intravesical bacillus Calmette-Guerin immunotherapy after previous prostate radiotherapy for high-grade non-muscle-invasive bladder cancer

Urologic Oncology Seminars and Original Investigations ◽

10.1016/j.urolonc.2011.07.005 ◽

2013 ◽

Vol 31 (6) ◽

pp. 857-861 ◽

Author(s):

Manoj V. Rao ◽

Chandy Ellimoottil ◽

Timothy Sondej ◽

Robert C. Flanigan ◽

Marcus L. Quek

Keyword(s):

Bladder Cancer ◽

Invasive Bladder Cancer ◽

Bacillus Calmette Guerin ◽

Muscle Invasive Bladder Cancer ◽

Prostate Radiotherapy ◽

Muscle Invasive

Download Full-text

Identification of genomic features underlying response of muscle-invasive bladder cancer (MIBC) to neoadjuvant sorafenib, gemcitabine, and cisplatin (SGC) in an open-label, single-arm, phase 2 study

Annals of Oncology ◽

10.1093/annonc/mdx371.025 ◽

2017 ◽

Vol 28 ◽

pp. v307

Author(s):

D. Raggi ◽

A. Paoli ◽

M. Dugo ◽

P. Giannatempo ◽

L. De Cecco ◽

...

Keyword(s):

Bladder Cancer ◽

Invasive Bladder Cancer ◽

Phase 2 ◽

Muscle Invasive Bladder Cancer ◽

Genomic Features ◽

Phase 2 Study ◽

Muscle Invasive ◽

Gemcitabine And Cisplatin

Download Full-text

Sex and Racial Disparities in the Treatment and Outcomes of Muscle-invasive Bladder Cancer

Urology ◽

10.1016/j.urology.2020.06.087 ◽

2020 ◽

Author(s):

Jessica Marinaro ◽

Alexander Zeymo ◽

Jillian Egan ◽

Filipe Carvalho ◽

Ross Krasnow ◽

...

Keyword(s):

Bladder Cancer ◽

Racial Disparities ◽

Invasive Bladder Cancer ◽

Muscle Invasive Bladder Cancer ◽

Muscle Invasive

Download Full-text

A prognostic immune predictor, HLA-DRA, plays diverse roles in non-muscle invasive and muscle invasive bladder cancer

Urologic Oncology Seminars and Original Investigations ◽

10.1016/j.urolonc.2020.11.017 ◽

2020 ◽

Author(s):

Xuan-Mei Piao ◽

Ho Won Kang ◽

Pildu Jeong ◽

Young Joon Byun ◽

Hee Youn Lee ◽

...

Keyword(s):

Bladder Cancer ◽

Invasive Bladder Cancer ◽

Muscle Invasive Bladder Cancer ◽

Muscle Invasive

Download Full-text

339: Selective Bladder Preservation by Transurethral Layer-Section in T2 Muscle-Invasive Bladder Cancer

The Journal of Urology ◽

10.1016/s0022-5347(18)30604-9 ◽

2007 ◽

Vol 177 (4S) ◽

pp. 114-115

Author(s):

Young Deuk Choi ◽

Kang Su Cho ◽

Soung Yong Cho ◽

Hyun Min Choi ◽

Nam Hoon Cho

Keyword(s):

Bladder Cancer ◽

Invasive Bladder Cancer ◽

Muscle Invasive Bladder Cancer ◽

Bladder Preservation ◽

Muscle Invasive

Download Full-text

A Study of Mitomycin-c/ Capecitabine ChemoRadiotherapy Combined With Nivolumab Monotherapy or Ipilumimab and Nivolumab, as Bladder Sparing Curative Treatment for Muscle Invasive Bladder Cancer: the CRIMI Study

Case Medical Research ◽

10.31525/ct1-nct03844256 ◽

2000 ◽

Author(s):

Keyword(s):

Bladder Cancer ◽

Mitomycin C ◽

Invasive Bladder Cancer ◽

Curative Treatment ◽

Muscle Invasive Bladder Cancer ◽

Muscle Invasive ◽

Bladder Sparing

Download Full-text

Bladder PREserVation by RadioTherapy and Immunotherapy in BCG Unresponsive Non-muscle Invasive Bladder Cancer

Case Medical Research ◽

10.31525/ct1-nct03950362 ◽

2019 ◽

Author(s):

Keyword(s):

Bladder Cancer ◽

Invasive Bladder Cancer ◽

Muscle Invasive Bladder Cancer ◽

Bladder Preservation ◽

Muscle Invasive

Download Full-text

Nivolumab Plus Chemoradiotherapy in Patients With Muscle-invasive Bladder Cancer (MIBC) Not Undergoing Cystectomy

Case Medical Research ◽

10.31525/ct1-nct03993249 ◽

2019 ◽

Author(s):

Keyword(s):

Bladder Cancer ◽

Invasive Bladder Cancer ◽

Muscle Invasive Bladder Cancer ◽

Muscle Invasive

Download Full-text

Rogaratinib for BCG Refractory High Risk Non-Muscle Invasive Bladder Cancer With FGFR1/2 Overexpression

Case Medical Research ◽

10.31525/ct1-nct04040725 ◽

2019 ◽

Author(s):

Keyword(s):

Bladder Cancer ◽

High Risk ◽

Invasive Bladder Cancer ◽

Muscle Invasive Bladder Cancer ◽

Muscle Invasive

Download Full-text

TRIO Bladder: A Phase Ib Study of Durvalumab (MEDI 4736) Plus Tremelimumab Followed by Concurrent Durvalumab Plus Bladder Radiation, Based on Molecular Subtypes in Muscle-Invasive Bladder Cancer

Case Medical Research ◽

10.31525/ct1-nct04073160 ◽

2019 ◽

Author(s):

Keyword(s):

Bladder Cancer ◽

Molecular Subtypes ◽

Invasive Bladder Cancer ◽

Muscle Invasive Bladder Cancer ◽

Phase Ib ◽

Muscle Invasive

Download Full-text